{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-26-007380","form_type":"8-K","ticker":"VTAK","cik":"0001716621","company_name":"Catheter Precision, Inc.","filed_at":"2026-03-09T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.987464+00:00","generated_at":"2026-05-15T17:58:00.540404+00:00","sec_items":["1.01","3.02","3.03","5.03","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Catheter Precision acquires 80% of Fly Flyte and Ponderosa Air for $11.6M; raises up to $39M in PIPE","bullets":["Acquisition of 80.02% of Fly Flyte, Inc. and 100% of Ponderosa Air from Creatd for $11.55M in cash and Series D preferred stock.","Private placement of Series C convertible preferred stock raises $1.85M at first close, potential additional raises up to $35.6M.","Proceeds used for restructuring legacy catheter business, potential sale of medical devices, and reducing cash burn.","Conversion prices start at $1.43, adjust to 80% of market with $0.35 floor, subject to stockholder approval.","Registration rights agreement filed to register resale of conversion shares within 30–60 days of closing."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-007380","json":"https://secwatch.observer/filing/0001437749-26-007380.json","markdown":"https://secwatch.observer/filing/0001437749-26-007380.md","text":"https://secwatch.observer/filing/0001437749-26-007380.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1716621/000143774926007380/0001437749-26-007380-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1716621/000143774926007380/vtak20260306_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T17:58:00.540404+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0db228ff7f6aefb7179405a44b66ead68e260571","claim":"Catheter Precision, Inc. issued 1,853 shares of Series C-3 Convertible Preferred Stock of preferred stock to accredited investors for aggregate purchase price of $1,853,000.00.","evidence_excerpt":"pursuant to the Financing Purchase Agreement, the Purchasers agreed to purchase (i) 1,853 shares of the Company’s newly-designated Series C-2 Convertible Preferred Stock, with a par value of $0.0001 per share and a stated value of $1,000 per share, for an aggregate purchase price of $1,853,000.00 (the “Series C-2 Preferred Stock”), and (ii) 1,853 shares of the Company’s newly-designated Series C-3 Convertible Preferred Stock, with a par value of $0.0001 per share and a stated value of $1,000 per share, for an aggregate purchase price of $1,853,000.00 (the “Series C-3 Preferred Stock” and, together with the Series C-1 Preferred Stock and Series C-2 Preferred Stock, the “Initial Preferred Stock”)","evidence_source":"SEC 8-K Item 3.02/3.03","evidence_url":"https://www.sec.gov/Archives/edgar/data/1716621/000143774926007380/0001437749-26-007380-index.htm","confidence":0.85,"family_label":"Equity Issuances","details":[{"label":"Security","value":"preferred stock"},{"label":"Shares","value":"1,853 shares of Series C-3 Convertible Preferred Stock"},{"label":"Purchaser","value":"accredited investors"},{"label":"Consideration","value":"aggregate purchase price of $1,853,000.00"}],"fact_type":"equity_issuance"},{"claim_id":"4ca7bfe5ba4dded7f1e7bf8f3979e79348c723a9","claim":"Catheter Precision, Inc. issued 1,853 shares of Series C-2 Convertible Preferred Stock of preferred stock to accredited investors for aggregate purchase price of $1,853,000.00.","evidence_excerpt":"pursuant to the Financing Purchase Agreement, the Purchasers agreed to purchase (i) 1,853 shares of the Company’s newly-designated Series C-2 Convertible Preferred Stock, with a par value of $0.0001 per share and a stated value of $1,000 per share, for an aggregate purchase price of $1,853,000.00 (the “Series C-2 Preferred Stock”), and (ii) 1,853 shares of the Company’s newly-designated Series C-3 Convertible Preferred Stock, with a par value of $0.0001 per share and a stated value of $1,000 per share, for an aggregate purchase price of $1,853,000.00 (the “Series C-3 Preferred Stock” and, together with the Series C-1 Preferred Stock and Series C-2 Preferred Stock, the “Initial Preferred Stock”)","evidence_source":"SEC 8-K Item 3.02/3.03","evidence_url":"https://www.sec.gov/Archives/edgar/data/1716621/000143774926007380/0001437749-26-007380-index.htm","confidence":0.85,"family_label":"Equity Issuances","details":[{"label":"Security","value":"preferred stock"},{"label":"Shares","value":"1,853 shares of Series C-2 Convertible Preferred Stock"},{"label":"Purchaser","value":"accredited investors"},{"label":"Consideration","value":"aggregate purchase price of $1,853,000.00"}],"fact_type":"equity_issuance"},{"claim_id":"d97714760b20ba8931f611d14d15a95ffeba4c57","claim":"Catheter Precision, Inc. issued 1,853 shares of Series C-1 Convertible Preferred Stock of preferred stock to accredited investors for aggregate purchase price of $1,853,000.","evidence_excerpt":"On March 9, 2026, Catheter Precision, Inc. (the “Company”) entered into a securities purchase agreement (the “Financing Purchase Agreement”) with certain accredited investors (collectively, the “Purchasers”) for the issuance and sale in a private placement (the “Private Placement Financing”) of an aggregate of 1,853 shares of the Company’s Series C-1 Convertible Preferred Stock, with a par value of $0.0001 per share and a stated value of $1,000 per share, initially convertible into up to 1,295,805 shares of common stock, par value $0.0001 per share (“Common Stock”), at an initial conversion price of $1.43 per share (the “Series C-1 Preferred Stock”) for an aggregate purchase price of $1,853,000","evidence_source":"SEC 8-K Item 3.02/3.03","evidence_url":"https://www.sec.gov/Archives/edgar/data/1716621/000143774926007380/0001437749-26-007380-index.htm","confidence":0.95,"family_label":"Equity Issuances","details":[{"label":"Security","value":"preferred stock"},{"label":"Shares","value":"1,853 shares of Series C-1 Convertible Preferred Stock"},{"label":"Purchaser","value":"accredited investors"},{"label":"Consideration","value":"aggregate purchase price of $1,853,000"}],"fact_type":"equity_issuance"},{"claim_id":"a6053ab3715b9606a5917fd642ab98f77061f848","claim":"Catheter Precision, Inc.: Amendment to Series C-1 Certificate of Designations to increase authorized shares from 1,783.33 to 3,636.33 (effective 2026-03-06).","evidence_excerpt":"In connection with the entrance into the Financing Purchase Agreement, the holders of the majority of the outstanding shares of Series C-1 Preferred Stock agreed to amend the Series C-1 Certificate of Designations by filing a Certificate of Amendment (“Certificate of Amendment”) to the Series C-1 Certificate of Designations with the Secretary of State of the State of Delaware (the “Secretary of State”) to increase the number of authorized shares of Series C-1 Preferred Stock from 1,783.33 to 3,636.33, in order to authorize a sufficient number of shares of Preferred Stock for the transactions contemplated by the Acquisition Purchase Agreement. On March 6, 2026, the Company filed the Certificate of Amendment with the Secretary of State, thereby amending the Certificate of Designations.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1716621/000143774926007380/0001437749-26-007380-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2026-03-06"}],"fact_type":"governance_change"},{"claim_id":"1b05553c7e4837cd1e36141edaa208a6a5f99557","claim":"Catheter Precision, Inc. entered into Financing Purchase Agreement with certain accredited investors valued at an aggregate purchase price of $1,853,000 (effective 2026-03-09).","evidence_excerpt":"On March 9, 2026, Catheter Precision, Inc. (the “Company”) entered into a securities purchase agreement (the “Financing Purchase Agreement”) with certain accredited investors (collectively, the “Purchasers”)","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1716621/000143774926007380/0001437749-26-007380-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"certain accredited investors"},{"label":"Value","value":"an aggregate purchase price of $1,853,000"},{"label":"Effective","value":"2026-03-09"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}